drugset / Trial / NCT07322991

Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.

NCT07322991

Phase 1 Completed 43 enrolled Il-Yang Pharm. Co., Ltd.
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this stud is to evaluate the drug-drug interaction between IY001 and IY002 in adult males.

Timeline

Start
2025-10-14
Primary completion
2025-12-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule
Subject Tamsulosin Other / unclassified

Indications

No indication recorded.